Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathway

Objective: Grain-sized moxibustion is an effective treatment for hyperlipidemia, but how it regulates dyslipidemia and liver lipid deposits still needs to be fully understood. This study explored the molecular biological mechanism of grain-sized moxibustion to regulate hepatic autophagy in hyperlipi...

Full description

Bibliographic Details
Main Authors: Qian Xu, Huanxi Wu, Haibin Zhu, Chengxuan Lu, Jiangjia Tao, Ziqiu Zhou, Jianbin Zhang
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844023025239
_version_ 1797815691195187200
author Qian Xu
Huanxi Wu
Haibin Zhu
Chengxuan Lu
Jiangjia Tao
Ziqiu Zhou
Jianbin Zhang
author_facet Qian Xu
Huanxi Wu
Haibin Zhu
Chengxuan Lu
Jiangjia Tao
Ziqiu Zhou
Jianbin Zhang
author_sort Qian Xu
collection DOAJ
description Objective: Grain-sized moxibustion is an effective treatment for hyperlipidemia, but how it regulates dyslipidemia and liver lipid deposits still needs to be fully understood. This study explored the molecular biological mechanism of grain-sized moxibustion to regulate hepatic autophagy in hyperlipidemic rats by affecting ULK1 and TFEB through the AMPK/mTOR signaling pathway. Methods: Thirty male Sprague-Dawley (SD) rats were fed a high-fat diet for eight weeks to induce hyperlipidemia. Hyperlipidemic rats were divided into the HFD group, HFD + Statin group, HFD + CC + Moxi group, and grain-sized moxibustion intervention group (HFD + Moxi group). The control (Blank) group consisted of normal rats without any intervention. Grain-sized moxibustion and drug interventions were initiated eight weeks after high-fat diet induction and continued for ten weeks. Serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL), as well as hepatic triglyceride (TG), were measured after treatment. Hepatic steatosis and the expression of LC3I, LC3II, p62, p-AMPK, AMPK, p-mTOR, mTOR, ULK1, p-ULK1, and TFEB in the liver were analyzed. Results: Compared with the HFD group, grain-sized moxibustion improved hyperlipidemia and hepatocyte steatosis, increased the LC3, p-AMPK, p-ULK1, and nuclear TFEB expression in the liver, but decreased the p62 and p-mTOR expression. Conclusion: Grain-sized moxibustion at ST36 acupoints could regulate the blood lipid level of SD rats with hyperlipidemia, increase the expression level of ULK1 and TFEB by activating the AMPK/mTOR signaling pathway in liver tissues, and initiate the transcription of autophagy genes such as LC3.
first_indexed 2024-03-13T08:26:30Z
format Article
id doaj.art-22ac9fee98a84084bbe6116f014848c9
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-03-13T08:26:30Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-22ac9fee98a84084bbe6116f014848c92023-05-31T04:44:32ZengElsevierHeliyon2405-84402023-05-0195e15316Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathwayQian Xu0Huanxi Wu1Haibin Zhu2Chengxuan Lu3Jiangjia Tao4Ziqiu Zhou5Jianbin Zhang6Jiangsu Second Hospital of Chinese Medicine, China; The Second Clinical Medical College/the Second Affiliated Hospital of Nanjing University of Chinese Medicine, ChinaJiangsu Second Hospital of Chinese Medicine, China; The Second Clinical Medical College/the Second Affiliated Hospital of Nanjing University of Chinese Medicine, ChinaJiangsu Second Hospital of Chinese Medicine, China; The Second Clinical Medical College/the Second Affiliated Hospital of Nanjing University of Chinese Medicine, ChinaCollege of Acupuncture and Tuina, Nanjing University of Chinese Medicine, ChinaJiangsu Second Hospital of Chinese Medicine, China; The Second Clinical Medical College/the Second Affiliated Hospital of Nanjing University of Chinese Medicine, ChinaJiangsu Second Hospital of Chinese Medicine, China; The Second Clinical Medical College/the Second Affiliated Hospital of Nanjing University of Chinese Medicine, ChinaJiangsu Second Hospital of Chinese Medicine, China; The Second Clinical Medical College/the Second Affiliated Hospital of Nanjing University of Chinese Medicine, China; Corresponding author.Jiangsu Second Hospital of Chinese Medicine, ChinaObjective: Grain-sized moxibustion is an effective treatment for hyperlipidemia, but how it regulates dyslipidemia and liver lipid deposits still needs to be fully understood. This study explored the molecular biological mechanism of grain-sized moxibustion to regulate hepatic autophagy in hyperlipidemic rats by affecting ULK1 and TFEB through the AMPK/mTOR signaling pathway. Methods: Thirty male Sprague-Dawley (SD) rats were fed a high-fat diet for eight weeks to induce hyperlipidemia. Hyperlipidemic rats were divided into the HFD group, HFD + Statin group, HFD + CC + Moxi group, and grain-sized moxibustion intervention group (HFD + Moxi group). The control (Blank) group consisted of normal rats without any intervention. Grain-sized moxibustion and drug interventions were initiated eight weeks after high-fat diet induction and continued for ten weeks. Serum total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL), as well as hepatic triglyceride (TG), were measured after treatment. Hepatic steatosis and the expression of LC3I, LC3II, p62, p-AMPK, AMPK, p-mTOR, mTOR, ULK1, p-ULK1, and TFEB in the liver were analyzed. Results: Compared with the HFD group, grain-sized moxibustion improved hyperlipidemia and hepatocyte steatosis, increased the LC3, p-AMPK, p-ULK1, and nuclear TFEB expression in the liver, but decreased the p62 and p-mTOR expression. Conclusion: Grain-sized moxibustion at ST36 acupoints could regulate the blood lipid level of SD rats with hyperlipidemia, increase the expression level of ULK1 and TFEB by activating the AMPK/mTOR signaling pathway in liver tissues, and initiate the transcription of autophagy genes such as LC3.http://www.sciencedirect.com/science/article/pii/S2405844023025239Grain-sized moxibustionST36HyperlipidemiaHepatic autophagyAMPK/mTOR
spellingShingle Qian Xu
Huanxi Wu
Haibin Zhu
Chengxuan Lu
Jiangjia Tao
Ziqiu Zhou
Jianbin Zhang
Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathway
Heliyon
Grain-sized moxibustion
ST36
Hyperlipidemia
Hepatic autophagy
AMPK/mTOR
title Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathway
title_full Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathway
title_fullStr Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathway
title_full_unstemmed Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathway
title_short Grain-sized moxibustion at Zusanli (ST36) promotes hepatic autophagy in rats with hyperlipidemia by regulating the ULK1 and TFEB expression through the AMPK/mTOR signaling pathway
title_sort grain sized moxibustion at zusanli st36 promotes hepatic autophagy in rats with hyperlipidemia by regulating the ulk1 and tfeb expression through the ampk mtor signaling pathway
topic Grain-sized moxibustion
ST36
Hyperlipidemia
Hepatic autophagy
AMPK/mTOR
url http://www.sciencedirect.com/science/article/pii/S2405844023025239
work_keys_str_mv AT qianxu grainsizedmoxibustionatzusanlist36promoteshepaticautophagyinratswithhyperlipidemiabyregulatingtheulk1andtfebexpressionthroughtheampkmtorsignalingpathway
AT huanxiwu grainsizedmoxibustionatzusanlist36promoteshepaticautophagyinratswithhyperlipidemiabyregulatingtheulk1andtfebexpressionthroughtheampkmtorsignalingpathway
AT haibinzhu grainsizedmoxibustionatzusanlist36promoteshepaticautophagyinratswithhyperlipidemiabyregulatingtheulk1andtfebexpressionthroughtheampkmtorsignalingpathway
AT chengxuanlu grainsizedmoxibustionatzusanlist36promoteshepaticautophagyinratswithhyperlipidemiabyregulatingtheulk1andtfebexpressionthroughtheampkmtorsignalingpathway
AT jiangjiatao grainsizedmoxibustionatzusanlist36promoteshepaticautophagyinratswithhyperlipidemiabyregulatingtheulk1andtfebexpressionthroughtheampkmtorsignalingpathway
AT ziqiuzhou grainsizedmoxibustionatzusanlist36promoteshepaticautophagyinratswithhyperlipidemiabyregulatingtheulk1andtfebexpressionthroughtheampkmtorsignalingpathway
AT jianbinzhang grainsizedmoxibustionatzusanlist36promoteshepaticautophagyinratswithhyperlipidemiabyregulatingtheulk1andtfebexpressionthroughtheampkmtorsignalingpathway